Fig. 1From: Effects of antirejection therapies for early subclinical acute rejection in renal transplant protocol biopsiesPatient selection based on inclusion/exclusion criteria. DSA, donor-specific antibody; PE, plasma exchange; FSGS, focal segmental glomerulosclerosis; BL, borderline changes; SAR, subclinical acute rejection; BL-t, borderline changes with antirejection therapies; and BL-o, borderline changes with observation and no antirejection therapiesBack to article page